Today: 28 June 2026
ASX Week Ahead: CPI Day and a Flood of Big Earnings Put Australian Shares to the Test

ASX Week Ahead: CPI Day and a Flood of Big Earnings Put Australian Shares to the Test

SYDNEY, Feb 22, 2026, 17:50 AEDT — Market is done for the day

  • ASX 200 heads into Monday near record highs, fueled by a streak of bank earnings.
  • Woodside, Woolworths, Qantas, and Coles are front and center on the local catalyst roster.
  • Rate expectations and valuations hinge most on inflation numbers right now.

The S&P/ASX 200 enters the week hovering near its recent record, with investors eyeing inflation data and the last round of major earnings to gauge if the index can sustain its run.

The index’s recent climb comes down to just a few big banks and some standout earnings plays pulling most of the weight. With leadership this thin, there’s hardly any cushion for letdowns, and the whole market reacts faster to news that could move interest rate expectations.

“Rate-sensitive” stocks usually take a hit on a hot CPI read, as higher-for-longer borrowing costs weigh. A softer inflation number, though, tends to support banks and defensives. As for earnings, they still have to deliver.

The S&P/ASX 200 edged down 4.8 points on Friday, closing at 9,081.4, after peaking at a record 9,118.3 just the day before. Still, the index finished the week 1.8% higher. Banks picked up 0.7% on Friday, capping their weekly advance at 2.8%, and helped offset a 0.7% drop in miners. “All the major banks have now reported and most delivered results ahead of consensus, triggering upgrades and a rotation back into the sector,” said Philip Pepe, senior equities analyst at Shaw and Partners. Indo Premier

Rio Tinto dropped as much as 4% Friday after its annual earnings landed flat, missing analyst forecasts. QBE Insurance, on the other hand, surged close to 6% following a full-year profit beat, helped by fewer catastrophe claims and improved investment income. Gold names were firmer—Perseus Mining jumped up to 5.5% after doubling its interim dividend. WiseTech slipped nearly 5%, with tech stocks echoing losses from Wall Street.

Another packed earnings stretch looms for the ASX 200. Woodside Energy will kick things off Tuesday, followed by Woolworths on Wednesday. Fortescue and WiseTech share that same day, offering updates on iron ore and logistics software. Qantas steps up Thursday, with Coles rounding out the week on Friday.

All eyes are on Wednesday’s January consumer price index, landing at 11:30 a.m. AEDT—a data drop that usually shakes the market, given its direct tie-in with the interest-rate story. CPI, shorthand for the price of a typical basket of goods and services, stands as the main yardstick for consumer inflation.

Westpac senior economist Justin Smirk is looking for a 0.1% increase in January CPI compared to December, and he figures the yearly rate will cool down to 3.6%. Smirk points to cheaper auto fuel and holiday travel likely balancing out higher prices in electricity and health services.

Risk remains a backdrop for global markets. According to IG, volatility around oil prices, uneasy U.S.-Iran relations, shifting expectations for U.S. rates, and scattered trouble in private credit have all contributed to turbulence abroad—despite Australian shares climbing higher.

The market isn’t exactly a bargain right now. MarketIndex puts the ASX 200 at roughly 19.5 times projected earnings for the next year—a figure that’s built on profit forecasts. The firm points out that any slip-up on earnings, especially with ongoing geopolitical tensions, AI-sector jitters, and “rate hike risks,” could quickly snowball into a broader retreat. Market Index

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Crypto Analyst Predicts 50x Surge for Aave, Outperforming Bitcoin by 2030
    June 28, 2026, 10:17 AM EDT. Bitcoin has declined over 50% since its October peak, amidst concerns about a crypto "Ponzi scheme" collapse. Geoff Kendrick, head of crypto research at Standard Chartered, forecasts a 50-fold surge in Aave's price-from $70 to $3,500-by 2030, positioning it to outperform Bitcoin and Ethereum. Aave, a major decentralized finance (DeFi) lending protocol with $12.4 billion locked in assets, suffered a $300 million exploit in April but remains a key player in DeFi, an emerging area Kendrick calls the next source of "generational wealth." He also predicts Bitcoin will reach $100,000 by 2026 and Ethereum $4,000. This highlights investor shifts towards DeFi amid faltering high-growth tech stocks and gold.

Latest articles

NVDA selloff drags $74 billion equity stake into spotlight

NVDA selloff drags $74 billion equity stake into spotlight

28 June 2026
Nvidia plunged 8.6% last week to $192.53, wiping out about $443 billion in equity value, as chip stocks suffered their worst week since April and Nvidia’s massive equity investment book added new risk to quarterly results; a further drop to $189.23 would mark a 20% slide from its May high.
AAPL volume spikes as QQQ faces memory squeeze risk

AAPL volume spikes as QQQ faces memory squeeze risk

28 June 2026
Apple (AAPL) surged 3.14% Friday on massive volume after a weeklong slide, but still lost $209 billion in value as memory chip price hikes forced iPad and MacBook increases; investors face margin pressure, supply-chain risks, and a short trading week with Apple now trading more on memory costs than iPhone cycles.
GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines
Previous Story

GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop